1Y Close · As of Aug 26, 2026
From Bio operates in the Food Products sector.
Legal name: From Bio Co., Ltd.
In fiscal year 2025, From Bio (377220) reported revenue of 72.2 billion KRW, up 7.4% from 67.2 billion KRW a year earlier.
Operating profit was -18.6 billion KRW and net income was -23.2 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 16.5 billion KRW, with a P/B of 0.63.
These figures can be verified in the DART filing (receipt no. 20260323001651).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 72.2B | -18.6B | -23.2B |
| 2024 | 67.2B | -24.3B | -26.2B |
| 2023 | 66.7B | -15.4B | -11.6B |
| 2022 | 99.3B | 897M | 1.3B |
| 2021 | 135.1B | 11.4B | 11.3B |
Recent Filings
Large Shareholding Report (General)
Officer/Major Shareholder Ownership Report
Semi-Annual Report (2026.06)
Checks
3 of 8 checked items currently applicable.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-19 | Large Shareholding Report (General) |
| 2026-08-19 | Officer/Major Shareholder Ownership Report |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-07 | Trading Halt Lifted (Reverse Split Re-listing) |